Reference sources: Sigma-Aldrich 5-Amino-1MQ (SML2832) | NIH PMC NNMT Inhibitor Research Regulatory Notice 5-Amino-1MQ is an unapproved new drug compound
Warnings: The use of cyanocobalamin is warned in patients with early Lebers disease as there have been reports of severe and swift optic atrophy with its administration
Under Billing Settings, scroll down to the section called Popular CPT codes
Effective preventative measures for patients at risk for cholelithiasis include a slower rate of weight loss, increasing/including some dietary fat in the diet (assuming the patient has been on a very low-calorie diet containing little or no fat), or administration of ursodeoxycholic acid
For patients on regular B12 injections, please see the video guide below on how to self administer your B12 injection.
It may help reduce body fat, shrink fat cells, increase energy, improve mitochondrial function, preserve muscle during weight loss, enhance insulin sensitivity, and support overall metabolic health